Short Interest in Intuitive Surgical, Inc. (NASDAQ:ISRG) Rises By 7.8%

Intuitive Surgical, Inc. (NASDAQ:ISRG) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 3,470,000 shares, a growth of 7.8% from the April 15th total of 3,220,000 shares. Based on an average trading volume of 1,460,000 shares, the short-interest ratio is currently 2.4 days.

Insiders Place Their Bets

In other news, VP Marshall Mohr sold 108,790 shares of the company’s stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the completion of the sale, the vice president now owns 26,877 shares of the company’s stock, valued at $10,349,795.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, VP Fredrik Widman sold 5,041 shares of the company’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the completion of the sale, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Marshall Mohr sold 108,790 shares of the company’s stock in a transaction dated Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the completion of the sale, the vice president now directly owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 148,290 shares of company stock worth $57,207,154. Company insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Hedge funds have recently added to or reduced their stakes in the company. Allworth Financial LP increased its stake in Intuitive Surgical by 5.5% in the third quarter. Allworth Financial LP now owns 7,018 shares of the medical equipment provider’s stock valued at $2,051,000 after purchasing an additional 367 shares during the last quarter. Money Concepts Capital Corp increased its stake in Intuitive Surgical by 3.7% in the third quarter. Money Concepts Capital Corp now owns 3,157 shares of the medical equipment provider’s stock valued at $922,000 after purchasing an additional 112 shares during the last quarter. Wisconsin Capital Management LLC increased its stake in Intuitive Surgical by 7.0% in the third quarter. Wisconsin Capital Management LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $2,054,000 after purchasing an additional 457 shares during the last quarter. New Mexico Educational Retirement Board increased its stake in Intuitive Surgical by 7.0% in the third quarter. New Mexico Educational Retirement Board now owns 18,242 shares of the medical equipment provider’s stock valued at $5,332,000 after purchasing an additional 1,200 shares during the last quarter. Finally, Congress Asset Management Co. MA increased its stake in Intuitive Surgical by 2.3% in the third quarter. Congress Asset Management Co. MA now owns 292,598 shares of the medical equipment provider’s stock valued at $85,523,000 after purchasing an additional 6,620 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ISRG. Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Piper Sandler upped their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday, April 19th. Mizuho upped their target price on shares of Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. Finally, Robert W. Baird decreased their target price on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $396.17.

Intuitive Surgical Stock Up 0.6 %

Shares of NASDAQ:ISRG opened at $398.82 on Friday. The firm’s 50 day moving average price is $384.97 and its 200 day moving average price is $357.63. The stock has a market cap of $141.46 billion, a price-to-earnings ratio of 71.99, a price-to-earnings-growth ratio of 5.16 and a beta of 1.39. Intuitive Surgical has a fifty-two week low of $254.85 and a fifty-two week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm’s revenue was up 11.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.00 earnings per share. On average, equities analysts anticipate that Intuitive Surgical will post 4.8 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.